Hana Must SPAC 2 (KQ:208370) — Market Cap & Net Worth
Market Cap & Net Worth: Hana Must SPAC 2 (208370)
Hana Must SPAC 2 (KQ:208370) has a market capitalization of $40.43 Million (₩59.66 Billion) as of September 19, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #22784 globally and #1494 in its home market, demonstrating a -2.52% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Hana Must SPAC 2's stock price ₩2320.00 by its total outstanding shares 25717579 (25.72 Million). Also see Hana Must SPAC 2 (208370) total assets for a full breakdown of the balance sheet.
Hana Must SPAC 2 Market Cap History: 2015 to 2026
Hana Must SPAC 2's market capitalization history from 2015 to 2026. Data shows change from $168.53 Million to $40.43 Million (-12.70% CAGR). Also see Hana Must SPAC 2 (208370) cash conversion ratio for how efficiently the company converts equity into cash flow.
Index Memberships
Hana Must SPAC 2 is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$235.78 Billion | 0.02% | #737 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$235.78 Billion | 0.02% | #737 of 1384 |
Weight: Hana Must SPAC 2's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Hana Must SPAC 2 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Hana Must SPAC 2's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check 208370 stock price and chart for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.00x
Hana Must SPAC 2's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.02x
Hana Must SPAC 2's market cap is 0.02 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $168.53 Million | $20.85 Billion | $166.90 Million | 0.01x | 1.01x |
| 2016 | $120.50 Million | $23.09 Billion | -$14.87 Billion | 0.01x | N/A |
| 2017 | $113.93 Million | $29.58 Billion | -$1.12 Billion | 0.00x | N/A |
| 2018 | $54.27 Million | $20.03 Billion | -$19.99 Billion | 0.00x | N/A |
| 2019 | $52.33 Million | $22.35 Billion | -$3.33 Billion | 0.00x | N/A |
| 2020 | $42.22 Million | $21.15 Billion | $758.70 Million | 0.00x | 0.06x |
| 2021 | $50.56 Million | $29.09 Billion | $2.47 Billion | 0.00x | 0.02x |
| 2022 | $35.22 Million | $27.69 Billion | $2.81 Billion | 0.00x | 0.01x |
| 2023 | $119.04 Million | $29.81 Billion | $5.17 Billion | 0.00x | 0.02x |
| 2024 | $70.67 Million | $31.70 Billion | $3.15 Billion | 0.00x | 0.02x |
Competitor Companies of 208370 by Market Capitalization
Companies near Hana Must SPAC 2 in the global market cap rankings as of September 19, 2026. Review 208370 goodwill-adjusted equity ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Hana Must SPAC 2 by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #124 globally with a market cap of $178.43 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #228 globally with a market cap of $109.30 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #238 globally with a market cap of $105.53 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #240 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #124 | Abbott Laboratories | NYSE:ABT | $178.43 Billion | $102.61 |
| #228 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $92.13 |
| #238 | Stryker Corporation | NYSE:SYK | $105.53 Billion | $275.12 |
| #240 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
Hana Must SPAC 2 Historical Marketcap From 2015 to 2026
Between 2015 and today, Hana Must SPAC 2's market cap moved from $168.53 Million to $ 40.43 Million, with a yearly change of -12.70%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩40.43 Million | -60.07% |
| 2025 | ₩101.26 Million | +43.28% |
| 2024 | ₩70.67 Million | -40.63% |
| 2023 | ₩119.04 Million | +237.95% |
| 2022 | ₩35.22 Million | -30.33% |
| 2021 | ₩50.56 Million | +19.76% |
| 2020 | ₩42.22 Million | -19.32% |
| 2019 | ₩52.33 Million | -3.57% |
| 2018 | ₩54.27 Million | -52.37% |
| 2017 | ₩113.93 Million | -5.45% |
| 2016 | ₩120.50 Million | -28.50% |
| 2015 | ₩168.53 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 19th, 2026 the market cap of Hana Must SPAC 2 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $40.43 Million USD |
| MoneyControl | $40.43 Million USD |
| MarketWatch | $40.43 Million USD |
| marketcap.company | $40.43 Million USD |
| Reuters | $40.43 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Hana Must SPAC 2
SELVAS Healthcare, Inc. operates as a medical device company in South Korea. The company provides body composition analyzers and automatic blood pressure monitors for hospitals. It also offers Braille Sense notetakers and other products for blind and visually impaired people under the HIMS brand name, as well as provides digital health products under the ACCUNIQ brand name. In addition, The compa… Read more